Section Arrow
SUPN.NASDAQ
- Supernus Inc
Quotes are at least 15-min delayed:2026/11/14 14:46 EST
Regular Hours
Last
 29.72
+0.52 (+1.78%)
Day High 
29.92 
Prev. Close
29.2 
1-M High
37.02 
Volume 
2.07M 
Bid
29.55
Ask
29.99
Day Low
28.81 
Open
29.41 
1-M Low
25.92 
Market Cap 
6.07B 
Currency 美元 
P/E -- 
%Yield 22.41 
10-SMA 29.59 
20-SMA 32.05 
50-SMA 34.02 
52-W High 42.81 
52-W Low 25.92 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.76/1.09
Enterprise Value
6.10B
Balance Sheet
Book Value Per Share
5.11
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
1.24B
Operating Revenue Per Share
2.94
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AKANAkanda Corp.1.36+0.6883+102.47%-- 
HLNHaleon plc9.17+0.08+0.88%18.97PE
HIMSHims & Hers Health19.73------ 
TEVATeva Pharmaceutical Industries Limited44.5+0.85+1.95%102.3PE
VTRSViatris20.82+0.15+0.73%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.